The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Regulatory News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

17 Jun 2016 15:48

RNS Number : 5998B
Silence Therapeutics PLC
17 June 2016
 

 

Results of AGM

 

17 June 2016

 

Silence Therapeutics plc, AIM: SLN, ("Silence" or "the Company"), a leader in the development and delivery of novel RNA therapeutics, announces that at its Annual General Meeting held earlier today, all resolutions were duly passed.

 

 

 

 

Enquiries:

 

Silence Therapeutics plc

Ali Mortazavi, Chief Executive Officer

Timothy Freeborn, Chief Financial Officer

Tel: +44 (0)20 3457 6900

 

Canaccord Genuity Limited (Nominated Adviser and Joint Broker)

Dr Julian Feneley/Henry Fitzgerald-O'Connor/Emma Gabriel

Tel: +44 (0)20 7523 8350

 

Peel Hunt LLP (Joint Broker)

James Steel/Oliver Jackson

 

Tel: +44 (0)20 7418 8900

Media Enquiries:

FTI Consulting

Simon Conway/Brett Pollard/Stephanie Cuthbert

Tel: +44 (0) 20 3727 1000

 

 

 

Notes to Editors:

 

About Silence Therapeutics plc

Our technology harnesses the body's natural mechanisms to create therapeutic effects within its own cells. This technology can selectively silence or replace any gene in the genome, modulating gene expression up as well as down in a variety of organs and cell types, in vivo. We have developed proprietary modifications to improve the robustness of RNA sequences, together with advanced liposomal chemistries to enhance the delivery of therapeutics.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGSFWFLWFMSELM
Date   Source Headline
4th Jun 20148:32 amRNSNotice of AGM
7th May 20145:05 pmRNSHolding(s) in Company
7th May 201412:03 pmRNSHolding(s) in Company
29th Apr 20144:30 pmRNSResult of Placing
28th Apr 20145:21 pmRNSProposed Placing to raise a minimum of £10 million
28th Apr 20147:00 amRNSGene knockdown in non-human primates
19th Mar 20147:02 amRNSPotential Equity Fundraising
19th Mar 20147:00 amRNSPreliminary Results - Year Ended 31 December 2013
27th Feb 20147:00 amRNSYear end trading update
26th Feb 201412:09 pmRNSHolding(s) in Company
24th Feb 20143:41 pmRNSHolding(s) in Company
23rd Jan 201411:35 amRNSHolding(s) in Company
4th Dec 201311:39 amRNSHolding(s) in Company
22nd Nov 20134:00 pmRNSHolding(s) in Company
21st Nov 20136:25 pmRNSHolding(s) in Company
20th Nov 20135:00 pmRNSGrant of Options and Additional Listing
18th Nov 20137:02 amRNSInvestor Event and Appointment of NOMAD
18th Nov 20137:01 amRNSDirectorate and senior management changes
18th Nov 20137:00 amRNSNew Clinical Trial
8th Nov 20135:33 pmRNSHolding(s) in Company
5th Nov 20137:00 amRNSHolding(s) in Company
23rd Oct 20137:00 amRNSInvestor Day
17th Oct 20135:50 pmRNSHolding(s) in Company
17th Oct 20135:50 pmRNSHolding(s) in Company
17th Oct 20135:50 pmRNSHolding(s) in Company
23rd Sep 20138:33 amRNSHalf Yearly Report
19th Sep 20137:00 amRNSDate of Interim Announcement
30th Aug 20132:46 pmRNSHolding(s) in Company
21st Aug 20137:00 amRNSDirectorate Change
16th Aug 201312:29 pmRNSHolding(s) in Company
8th Aug 20137:00 amRNSAtu027 Phase I/II Update
12th Jul 20134:32 pmRNSHolding(s) in Company
3rd Jul 20137:00 amRNSCancellation of warrants
26th Jun 20132:47 pmRNSResult of AGM
26th Jun 20139:00 amRNSIssue of Options
26th Jun 20137:00 amRNSDirectorate Change
18th Jun 20137:00 amRNSAtu027 update: progression into Phase IIa
7th Jun 20134:35 pmRNSPrice Monitoring Extension
3rd Jun 20134:35 pmRNSPrice Monitoring Extension
3rd Jun 201311:30 amRNSNotice of AGM
29th May 20137:01 amRNSFinal Results
29th May 20137:00 amRNSDirectorate Change
2nd May 20134:52 pmRNSHolding(s) in Company
2nd May 20133:55 pmRNSHolding(s) in Company
2nd May 20133:52 pmRNSHolding(s) in Company
2nd May 20133:26 pmRNSHolding(s) in Company
29th Apr 201312:15 pmRNSResult of EGM
10th Apr 20137:00 amRNSPlacing and Share Consolidation
8th Mar 20137:00 amRNSExercise of warrants
5th Mar 20139:00 amRNSBusiness Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.